- Home
- / Biostar Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biostar Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2022-08-02
Market Capitalization
$3.2 K
2022-08-02
Revenue
$2.4 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 92.0M | 49.3M | 52.7M | 61.4M | 27.1M | 2.4M |
| Cost of goods sold | 27.6M | 19.5M | 27.0M | 31.1M | 16.0M | 1.5M |
| Gross profit | 64.4M | 29.9M | 25.7M | 30.3M | 11.1M | 915.2K |
| Gross profit margin, % | 70.0% | 60.5% | 48.7% | 49.3% | 40.9% | 38.4% |
| General and administrative expense | 5.7M | 6.0M | 6.1M | 7.7M | 4.6M | 2.4M |
| Operating expense total | 46.2M | 51.6M | 25.2M | 31.6M | 34.9M | 4.5M |
| EBIT | 18.2M | (21.8M) | 508.2K | (1.3M) | (23.8M) | (3.6M) |
| EBIT margin, % | 19.7% | -44.2% | 1.0% | -2.1% | -87.6% | -149.5% |
| Interest income | 430.0K | 296.1K | 1.3M | 1.3M | 8.9K | 1.2K |
| Interest expense | 41.9K | 84.4K | 2.1M | 2.8M | 35.2K | 518.9K |
| Pre tax profit | 18.1M | (21.6M) | 2.7M | 1.5M | (23.8M) | (3.0M) |
| Income tax expense | 5.9M | (1.6M) | 1.8M | (3.3M) | 1.3M | 2.7M |
| Net Income | 12.2M | (20.0M) | 809.0K | 4.8M | (25.1M) | (5.7M) |